Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Evelo Biosciences Inc (EVLO)

Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evelo Biosciences Inc One Kendall Square 600/700 Suite 7-201 Cambridge MA 02139 USA

www.evelobio.com P: 617-577-0300

Description:

Evelo Biosciences, Inc. operates as a bio-technology company. It develops therapies for the treatment of the gut-body network. The company also offers treatment for cancer and inflammatory diseases. Its product portfolio consists of EDP1066 which are in clinical stage. Evelo Biosciences is based in Massachusetts, United States.

Key Statistics

Overview:

Market Capitalization, $K 835
Enterprise Value, $K -3,495
Shares Outstanding, K 18,983
Annual Sales, $ 0 K
Annual Net Income, $ -114,530 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -12,360 K
EBIT, $ -76,740 K
EBITDA, $ -74,680 K
60-Month Beta 2.03
% of Insider Shareholders 1.02%
% of Institutional Shareholders 0.31%
Float, K 18,789
% Float 98.98%
Short Volume Ratio 0.01

Growth:

1-Year Return -98.45%
3-Year Return -99.98%
5-Year Return -99.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.66 on 11/09/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -13.01
EPS Growth vs. Prev Qtr 81.41%
EPS Growth vs. Prev Year 88.21%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 06/30/23

EVLO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity -1.27
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.42
Interest Coverage -23.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar